Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Drug Safety
List of Issues
Volume 10, Issue 3

Expert Opinion on Drug Safety

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Drug Safety, Volume 10, Issue 3 (2011)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Safety, Volume 10, Issue 3 (2011)

See all volumes and issues

Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Vol 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Volume 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Article

Use of the self-controlled case series method in drug safety assessment

Anthony Grosso, Ian Douglas, Raymond MacAllister, Irene Petersen, Liam Smeeth & Aroon D Hingorani

Pages: 337-340

Published online: 15 Mar 2011

First Page PreviewforUse of the self-controlled case series method in drug safety assessment | Full Text | References | PDF (202.9 KB)

248 Views
8 CrossRef citations
0Altmetric

Article

The safety of atypical antipsychotics: does QTc provide all the answers?

Jimmi Nielsen

Pages: 341-344

Published online: 20 Apr 2011

AbstractforThe safety of atypical antipsychotics: does QTc provide all the answers? | Full Text | References | PDF (161.2 KB)

265 Views
8 CrossRef citations
0Altmetric

Original Research

Article

The role of S-adenosyl methionine in preventing FOLFOX-induced liver toxicity: a retrospective analysis in patients affected by resected colorectal cancer treated with adjuvant FOLFOX regimen

Bruno Vincenzi, Daniele Santini, Anna Maria Frezza, Pierpaolo Berti, Umberto Vespasiani, Antonio Picardi & Giuseppe Tonini

Pages: 345-349

Published online: 15 Mar 2011

AbstractforThe role of S-adenosyl methionine in preventing FOLFOX-induced liver toxicity: a retrospective analysis in patients affected by resected colorectal cancer treated with adjuvant FOLFOX regimen | Full Text | References | PDF (175.2 KB)

295 Views
13 CrossRef citations
0Altmetric

Reviews

Article

Immune alterations in untreated and treated myelodysplastic syndrome

Prerna Mewawalla MD & Constantin A Dasanu MD PhD

Pages: 351-361

Published online: 21 Mar 2011

AbstractforImmune alterations in untreated and treated myelodysplastic syndrome | Full Text | References | PDF (216.6 KB)

331 Views
6 CrossRef citations
0Altmetric

Article

Safety review of combination drugs for hyperlipidemia

Michel Farnier MD PhD

Pages: 363-371

Published online: 22 Mar 2011

AbstractforSafety review of combination drugs for hyperlipidemia | Full Text | References | PDF (203.5 KB)

526 Views
13 CrossRef citations
0Altmetric

Article

Statin-induced myopathy: a review and update

Thura T Abd MD MPH & Terry A Jacobson MD

Pages: 373-387

Published online: 23 Feb 2011

AbstractforStatin-induced myopathy: a review and update | Full Text | References | PDF (444.1 KB)

6256 Views
211 CrossRef citations
0Altmetric

Article

From old to new nucleoside reverse transcriptase inhibitors: changes in body fat composition, metabolic parameters and mitochondrial toxicity after the switch from thymidine analogs to tenofovir or abacavir

Adrian Curran MD & Esteban Ribera MD PhD

Pages: 389-406

Published online: 17 Jan 2011

AbstractforFrom old to new nucleoside reverse transcriptase inhibitors: changes in body fat composition, metabolic parameters and mitochondrial toxicity after the switch from thymidine analogs to tenofovir or abacavir | Full Text | References | PDF (238.8 KB)

245 Views
23 CrossRef citations
0Altmetric

Article

Chemotherapy-induced peripheral neuropathies: from clinical relevance to preclinical evidence

David Balayssac, Jérémy Ferrier, Juliette Descoeur, Bing Ling, Denis Pezet, Alain Eschalier & Nicolas Authier

Pages: 407-417

Published online: 06 Jan 2011

AbstractforChemotherapy-induced peripheral neuropathies: from clinical relevance to preclinical evidence | Full Text | References | PDF (216.9 KB)

901 Views
85 CrossRef citations
0Altmetric

Article

The safety of thiazolidinediones

Keith G Tolman MD FACP

Pages: 419-428

Published online: 03 Mar 2011

AbstractforThe safety of thiazolidinediones | Full Text | References | PDF (208.7 KB)

465 Views
42 CrossRef citations
0Altmetric

Article

Pegylated-interferon-α_2a in clinical practice: how to manage patients suffering from side effects

Vincenza Calvaruso, Marta Mazza & Piero L Almasio

Pages: 429-435

Published online: 16 Feb 2011

AbstractforPegylated-interferon-α_2a in clinical practice: how to manage patients suffering from side effects | Full Text | References | PDF (192.3 KB)

307 Views
16 CrossRef citations
0Altmetric

Drug Safety Evaluations

Article

Drug safety evaluation of ziprasidone

Leslie Citrome MD MPH

Pages: 437-448

Published online: 19 Feb 2011

AbstractforDrug safety evaluation of ziprasidone | Full Text | References | PDF (270 KB)

431 Views
22 CrossRef citations
0Altmetric

Article

Safety evaluation of aprepitant for the prevention of chemotherapy-induced nausea and vomiting

Christina H Ruhlmann MD & Jørn Herrstedt MD DMSci

Pages: 449-462

Published online: 21 Mar 2011

AbstractforSafety evaluation of aprepitant for the prevention of chemotherapy-induced nausea and vomiting | Full Text | References | PDF (272.1 KB)

435 Views
11 CrossRef citations
0Altmetric

Article

Safety of omalizumab in asthma

Ricardo A Tan MD & Jonathan Corren MD

Pages: 463-471

Published online: 15 Mar 2011

AbstractforSafety of omalizumab in asthma | Full Text | References | PDF (194.9 KB)

889 Views
25 CrossRef citations
0Altmetric

Article

Drug safety evaluation of exemestane

Anneleen Lintermans, Patrick Neven MD PhD & Robert Paridaens MD PhD

Pages: 473-487

Published online: 24 Mar 2011

AbstractforDrug safety evaluation of exemestane | Full Text | References | PDF (284.6 KB)

368 Views
6 CrossRef citations
0Altmetric

Letter to the Editor

Correction

Letter to the Editor

Juergen Scholze

Page: 489

Published online: 17 Mar 2011

CitationforLetter to the Editor | Full Text | References | PDF (136.3 KB)

39 Views
0 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Quantification of Longitudinal Patient-Reported Burden of Adverse Drug Reactions Attributed to the Use of TNF-α Inhibitors in inflammatory rheumatic diseases: an observational prospective cohort study

Benthe H. König et al.

Article | Published online: 23 Jul 2024

Real-world safety and effectiveness of intravenous fomepizole in patients with ethylene glycol and methanol poisoning in Japan: results of a 7-year post-marketing surveillance study

Toshiharu Yoshioka et al.

Article | Published online: 22 Jul 2024

Open Access

Safety assessment of sildenafil use in neonates: a real-world data analysis based on the FDA adverse event reporting system (FAERS)

Bo Wang et al.

Article | Published online: 22 Jul 2024

Assessment of adverse events of the novel cardiovascular drug vericiguat: a real-world pharmacovigilance study based on FAERS

Jin Rao et al.

Article | Published online: 19 Jul 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Drug Safety (Vol.10, Iss.3, 2011)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?